ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogs

Guiqiang Wang, Yimin Cui, Yao Xie, Qianguo Mao, Qing Xie, Ye Gu, Xinyue Chen, Guoxin Hu, Yongfeng Yang, Jiajie Lu, Guizhou Zou, Qin Zhang, Lei Fu, Yong‐Ping Chen, Xiaolin Guo, Jinlin Hou, Yue-Mei Yan, Handan He, Jinzi J. Wu